If the consumed item has a High GI and GL, it will primarily take Pathway number one (1). If the food has a Low GI and GL, it will primarily take Pathway number two (2).

Quickly digested and metabolized foods possess the highest glycemic indices. Slowly digested foods release glucose gradually into the bloodstream, and are therefore, typically low glycemic.

All foods, drinks, and Nutraceuticals can be categorized as either high or low glycemic:

The Glycemic Index (GI) reflects the type and/or quality of carbohydrates in a particular food or edible agent, and how a specific portion of this food reacts metabolically as it is digested in the human digestive tract.

The four major areas that are tracked during glycemic clinical studies include how the ingested food:

The glycemic response of a food also reflects the metabolic response to various percentages of protein, fat, and carbohydrates present in the food, which alter its glycemic response. Contrary to popular opinion, pure protein, eaten without carbohydrates, does elicit an insulin response, particularly in diabetics.

For example, milk (and protein drinks containing milk or protein without any additional carbohydrates) is a particularly potent insulin secretagogue, as the observed insulin response in clinical studies is about 5-fold greater than would be anticipated from the glucose response. This explains why excess milk ingestion can cause rapid weight gain (as is the case with bottle-fed infants).

In adults, excess milk or protein ingestion combined with lack of exercise, and inadequate muscle mass, results in excess body fat. Ingesting more than 30 grams of protein at one time results in automatic shunting of calories into adipose tissue fat cells, thus increasing abdominal girth. This is true in normal sized persons or large sized persons, such as 250-pound body builders, because excess protein will always stimulate fat-storage, despite the size of the individual. Protein powders that deliver more than 30 grams of protein cause increases in fat cell size, even in elite athletes.

ADIPOSE TISSUE FAT STORAGE

In humans, clinical measurements can be taken that identify the fat-storing properties of a food, and its path of metabolism. All foods, drinks, and Nutraceutical products (such as Meal Replacement drinks) are either burned as energy in the body or shunted into adipose tissue fat cells. Clinical studies can track the metabolic pathway of the food ingested, to discover if it is burned or stored.

Adipose Tissue Fat Studies focus on identification of the proclivity and ability of a “Test Food” to stimulate fat-storage in fat cells via stimulation of human fat-storing enzymes and mechanisms. During glycemic clinical studies, Test Foods can be clinically analyzed In Vivo to determine their metabolic fat-storing properties with optional specific focus on insulin-resistance disorders.

Understanding the fat-stimulating properties of foods allows for better control over food-driven fat-storage, obesity, insulin stimulation, reactive hypoglycemia, as well as exacerbation and development of Metabolic Syndrome, Insulin-Resistance, and type 2 diabetes.

Example: The glycemic index of one packet of Sweet’N Low or Equal is high (per clinical studies), but the glycemic load of one packet is low. If one packet of the sweeteners is consumed, no prominent glycemic response is evidenced. But if multiple packets are consumed, the glycemic load can be significant, triggering fat-storage and elevated blood glucose.

Glycemic load (GL) is calculated as the glycemic index multiplied by grams of carbohydrate per serving size. Glycemic Load is based on a specific quantity and carbohydrate content of a test food. GL is calculated by multiplying the weighted mean of the dietary glycemic index by the percentage of total energy from the test food. When the test food contains quantifiable carbohydrates, the Glycemic Load equals GI (%) x grams of carbohydrate per serving. One unit of GL approximates the glycemic effect of 1 gram of glucose. Typical diets contain from 60-180 GL units per day.

Insulin secretion and insulin sensitivity (SI) are directly involved in the pathogenesis of diabetes, so avoidance of insulin elevation is mandatory in preventing Type 2 diabetes and other diseases related to insulin-elevation. Increased dietary glycemic load results in increased glycemia and insulin, which leads to obesity, increased risk of diabetes, and increased risk of some forms of cancer. High dietary glycemic index and load have a proven association with insulin resistance-related diseases. Therefore, glycemic index and daily glycemic load should be considered in long-term control over excess body fat, and prevention of Type 2 diabetes.